Literature DB >> 32355686

Modulation of the gut microbiota represents a new management for non-alcoholic fatty liver disease.

Farnush Bakhshimoghaddam1, Mohammad Alizadeh2.   

Abstract

Entities:  

Year:  2020        PMID： 32355686      PMCID： PMC7188533          DOI： 10.21037/hbsn.2019.10.01

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

Review 1.  Prebiotic effects: metabolic and health benefits.

Authors:  Marcel Roberfroid; Glenn R Gibson; Lesley Hoyles; Anne L McCartney; Robert Rastall; Ian Rowland; Danielle Wolvers; Bernhard Watzl; Hania Szajewska; Bernd Stahl; Francisco Guarner; Frederique Respondek; Kevin Whelan; Veronique Coxam; Marie-Jeanne Davicco; Laurent Léotoing; Yohann Wittrant; Nathalie M Delzenne; Patrice D Cani; Audrey M Neyrinck; Agnes Meheust
Journal:  Br J Nutr       Date:  2010-08       Impact factor: 3.718

Review 2.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

3.  Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD).

Authors:  Valentina Volynets; Markus A Küper; Stefan Strahl; Ina B Maier; Astrid Spruss; Sabine Wagnerberger; Alfred Königsrainer; Stephan C Bischoff; Ina Bergheim
Journal:  Dig Dis Sci       Date:  2012-03-17       Impact factor: 3.199

4.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

Authors:  Luca Miele; Venanzio Valenza; Giuseppe La Torre; Massimo Montalto; Giovanni Cammarota; Riccardo Ricci; Roberta Mascianà; Alessandra Forgione; Maria L Gabrieli; Germano Perotti; Fabio M Vecchio; Gianlodovico Rapaccini; Giovanni Gasbarrini; Chris P Day; Antonio Grieco
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

Review 5.  Bacterial infections, sepsis, and multiorgan failure in cirrhosis.

Authors:  Puneeta Tandon; Guadalupe Garcia-Tsao
Journal:  Semin Liver Dis       Date:  2008-02       Impact factor: 6.115

Review 6.  Probiotics: a potential target for the prevention and treatment of steatohepatitis.

Authors:  Gerardo Nardone; Alba Rocco
Journal:  J Clin Gastroenterol       Date:  2004-07       Impact factor: 3.062

7.  Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.

Authors:  Zhiping Li; Shiqi Yang; Huizhi Lin; Jiawen Huang; Paul A Watkins; Ann B Moser; Claudio Desimone; Xiao-yu Song; Anna Mae Diehl
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

8.  Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.

Authors:  Farnush Bakhshimoghaddam; Kamran Shateri; Morad Sina; Maryam Hashemian; Mohammad Alizadeh
Journal:  J Nutr       Date:  2018-08-01       Impact factor: 4.798

Review 9.  Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.

Authors:  Yan-Yan Ma; Lin Li; Chao-Hui Yu; Zhe Shen; Li-Hua Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

Review 10.  Impact of the gut microbiota on inflammation, obesity, and metabolic disease.

Authors:  Claire L Boulangé; Ana Luisa Neves; Julien Chilloux; Jeremy K Nicholson; Marc-Emmanuel Dumas
Journal:  Genome Med       Date:  2016-04-20       Impact factor: 11.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.